Diaphragm Pacing Device MARKET REPORT OVERVIEW
-
Request a Free Sample to learn more about this report
The global Diaphragm Pacing Device Market size was USD 4 billion in 2019 and will touch USD 6 billion by 2026, exhibiting a CAGR of 5.3% during the forecast period.
It is a mechanical system is an option used by patients suffering with extremely critical health conditions and are one ventilators as they cannot breathe on their own. These devices helps the respiratory system of the patient to respire as if doing normally. It works part-time and full-time both.
It is also used by the patients who have chronic respiratory disorders and have weak lungs, diaphragm, and other respiratory organs. It improves their quality of life by helping them to breathe properly.
COVID-19 Impact: Market Growth Boosted by Pandemic due to Increased Chronic Illnesses
The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.
The R&D was completely disrupted of many companies during the COVID period. This disruption led to delays and disturbance in the supply, demand and manufacturing of the companies as well. These disruptions happened to cause a chaos as the demand was high and the supply of the medical and pharmaceutical devices was under satisfactory, which in terms affected the Diaphragm Pacing Device Market growth. Health conditions all over the world were high during the pandemic which proportionally led to a hike in the shares of the medical sector. Apart from the pandemic people also suffered from various other diseases during the same period which led to the increased usage of the this device as chronic illnesses got power over humans.
LATEST TRENDS
"Advanced features to Drive Market Growth"
DP enhances speech, olfaction, movement, and overall quality of life. There is no longer a risk of the ventilator disconnecting and the shame associated with being dependent on a mechanical equipment. Reduction in respiratory infections and rising patient mobility are contributing factors to the external diaphragm pacemaker industry's expansion and will open up new chances for the diaphragm pacing device market throughout the projected period.
Diaphragm Pacing Device MARKET SEGMENTATION
-
Request a Free Sample to learn more about this report
By Type
Based on type the global market can be categorized into External Diaphragm Pacemaker and Diaphragm Pacemaker amongst which the leading segment is the External Diaphragm Pacemaker.
- External Diaphragm Pacemaker: By stimulating the phrenic nerve, which in turn causes the diaphragm to contract passively and regularly, external diaphragmatic pacing is a passive respiratory muscle exercise technique that aids in the rehabilitation of diaphragmatic dysfunction.
- Diaphragm Pacemaker: When someone with spinal cord injury uses a mechanical ventilator, diaphragm pacing can aid with breathing, speech, and overall quality of life. Possibly reducing reliance on a mechanical ventilator is possible with diaphragm pacing. You strengthen your diaphragm muscles and nerves with a lightweight, battery-operated device when you use diaphragm pacing device. You can breathe more easily as a resulting in the contraction of your diaphragm for better functioning of the respiratory system Both internal and external body components are used in diaphragm pacing device.
By Application
Based on application the global market can be categorized into SCI, ALS, and Other amongst which the leading segment is the SCI.
- SCI: Serious medical conditions like spinal cord injury (SCI) frequently leave victims severely sick and permanently disabled. It happens when the nerves that pass through the spinal cord's axons are damaged, which results in the loss of motor and sensory function below the site of the lesion. It improves the quality of life and aids in the recovery of patients who require mechanical ventilation due to speech or movement issues.
- ALS: Breathing might become challenging when ALS weakens the muscles in the chest. As a matter of fact, respiratory issues have long been one of the main causes of death for ALS patients. Diaphragm involvement is the primary cause of frank respiratory failure in ALS patients. Early morphometric alterations in these neurons indicate that the phrenic nerve motor nuclei in the cervical spinal cord are situated in an area that is early impacted by ALS. In these situations, the main goal of diaphragm pacing is to induce muscular conditioning by utilizing the disease's diverse muscle involvement; however, other outcomes (such as enhanced lung compliance, higher alveolar ventilation, or atelectasis prevention) may also occur.
DRIVING FACTORS
"Increased SCI and ALS diseases to boost the Market Growth"
The primary market drivers of the worldwide diaphragm pacing device market are the rising incidence of ALS and the increasing prevalence of SCI (Spinal Cord Injuries). In addition, the global market is growing significantly due to the increasing breakthroughs in technology and the increasing number of product releases and innovations in the relevant segment. The diaphragm pacing device is driving the market because of its many advantages, which include reducing the need for mechanical ventilators and enabling patients to breathe more naturally and efficiently.
"Rise in usage of Diaphragm pacing device in developing nations to expand the Market Growth"
The market will rise as a result of the various uses for diaphragm pacing devices, including helping patients breathe and speak better and reducing their reliance on mechanical ventilators. The reason for the expansion of the market for external diaphragm pacemakers is due to their usage in the management of spinal cord injuries and chronic respiratory disorders which often prove life threatening. The diaphragm pacing market share is expanding because the diaphragm pacemaker always worries about power interruptions and external power sources.
RESTRAINING FACTOR
"High Cost of Machinery to Impede Market Growth"
A diaphragm pacing device is costly because it needs intricate and hefty precast components. It can take some practice to become comfortable inserting the diaphragm because some people find it difficult. If there is excessive forceful pushing, diaphragms may be forced out of position.
Diaphragm Pacing Device MARKET REGIONAL INSIGHTS
-
Request a Free Sample to learn more about this report
"North America to Dominate the Market due to Large Population"
The market is primarily segmented into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.
Due to its high disposable income, growing healthcare costs, and growing incidence of respiratory illnesses such sleep apnea, spinal cord injuries, and amyotrophic lateral sclerosis, North America leads the world market for diaphragm pacing devices. Additionally, rising patient disposable incomes and bettering healthcare costs are anticipated to support regional market expansion.
KEY INDUSTRY PLAYERS
"Key Players Focus on Partnerships to Gain a Competitive Advantage"
Prominent market players are making collaborative efforts by partnering with other companies to stay ahead of the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolios.
List of Market Players Profiled
- Avery Biomedical Devices (U.S.)
- Synapse Biomedical (U.S.)
- Atrotech (Germany)
- Arahelio (China)
INDUSTRIAL DEVELOPMENT
March 2023: In March 2023, Synapse Biomedical, Inc. launched a new device NeuRx Diaphragm Pacing System (NeuRx DPS).
REPORT COVERAGE
This research profiles a report with extensive studies that take into description the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, and restraints. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.
REPORT COVERAGE | DETAILS |
---|---|
Market Size Value In |
US$ 4 Million in 2019 |
Market Size Value By |
US$ 6 Million by 2026 |
Growth Rate |
CAGR of 5.3% from 2019 to 2026 |
Forecast Period |
2022-2026 |
Base Year |
2023 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
Types & Application |
Frequently Asked Questions
-
What value is the Diaphragm Pacing Device Market expected to touch by 2026?
The Diaphragm Pacing Device Market is expected to reach USD 6 million by 2026.
-
What CAGR is the Diaphragm Pacing Device Market expected to exhibit by 2026?
The Diaphragm Pacing Device Market is expected to exhibit a CAGR of 5.3% by 2026.
-
Which are the driving factors of the Diaphragm Pacing Device Market?
Increased SCI and ALS diseases & Rise in usage of Diaphragm pacing device in developing nations are some of the driving factors of the Diaphragm Pacing Device market.
-
What are the key Diaphragm Pacing Device Market segments?
The Diaphragm Pacing Device market segmentation that you should be aware of, which include, based on type the Diaphragm Pacing Device Market is classified as External Diaphragm Pacemaker and Diaphragm Pacemaker. Based on application the Diaphragm Pacing Device Market is classified as SCI, ALS, and Other.